The exclusion of acquisition costs and inventory and demonstration inventory step-up amortization from the three month periods ended March 31, 2019 and the addition of these items to the three month period ended March 31, 2018.
Management has the ability, if necessary, to liquidate any of its investments in order to meet the Companys liquidity needs in the next 12 months.
The exclusion of debt issuance costs due to the modification of the Incremental Term Loan Facility from the three month period ended March 31, 2019 and the addition of this item to the three month period ended March 31, 2018.
Tax expense (benefit) was $15 and ($112) for the three months ended March 31, 2019 and 2018, respectively.
Tax benefit was $21 and $36 for the three months ended March 31, 2019 and 2018, respectively.
Tax benefit was $16 and $17 for the three months ended March 31, 2019 and 2018, respectively.
There were no SARs granted during the three months ended March 31, 2019 or 2018.
The net increase was primarily attributable to the addition of historical gross unrecognized tax benefits for ESI as a result of the ESI Merger during the quarter ended March 31, 2019.
The market participants usually are large commercial banks.
The Companys effective tax rates for the three months ended March 31, 2019 and 2018 were 18.8% and 17.1%, respectively.
The Companys primary served markets include semiconductor, industrial technologies, life and health sciences, research and defense.
The Company recorded restructuring charges of $223 during the three months ended March 31, 2019, primarily related to severance costs related to the consolidation of certain functions in Asia.Selling, general and administrative expenses decreased by $0.4 million for the three months ended March 31, 2019, compared to the same period in the prior year.
Net cash provided by operating activities was $29.1 million for the three months ended March 31, 2019 and resulted from net income of $12.5 million, which included non-cash charges of $61.6 million, offset by a net increase in working capital of $45.0 million.
Net cash provided by operating activities was $72.7 million for the three months ended March 31, 2018 and resulted from net income of $105.1 million, which included non-cash charges of $37.9 million, offset by a net increase in working capital of $70.3 million.
Gross profit as a percentage of net product revenues decreased by 5.2 percentage points for the three months ended March 31, 2019, compared to the same period in the prior year, primarily due lower revenue volumes and lower factory utilization.
Total international net revenues, including product and service, were $239.2 million and $277.6 million for the three months ended March 31, 2019, compared to the same period in the prior year.
Gross profit as a percentage of net service revenues decreased by 1.7 percentage points for the three months ended March 31, 2019, compared to the same period in the prior year, primarily due to unfavorable product mix partially offset by favorable absorption.al v. Electro Scientific Industries, Inc. et al., Christopher Stanley et.